233 related articles for article (PubMed ID: 26929254)
1. The Predictive Value of Platelet/Lymphocyte Ratio in Hemodialysis Patients With Erythropoietin Resistance.
Taymez DG; Ucar E; Turkmen K; Ucar R; Afsar B; Gaipov A; Turk S
Ther Apher Dial; 2016 Apr; 20(2):118-21. PubMed ID: 26929254
[TBL] [Abstract][Full Text] [Related]
2. The relationship between depressive symptoms and erythropoietin resistance in stable hemodialysis patients with adequate iron stores.
Afsar B
Int J Artif Organs; 2013 May; 36(5):314-9. PubMed ID: 23645578
[TBL] [Abstract][Full Text] [Related]
3. The relationship between red cell distribution width with erythropoietin resistance in iron replete hemodialysis patients.
Afsar B; Saglam M; Yuceturk C; Agca E
Eur J Intern Med; 2013 Apr; 24(3):e25-9. PubMed ID: 23246125
[TBL] [Abstract][Full Text] [Related]
4. Comparison of erythropoietin resistance in hemodialysis patients using calcitriol, cinacalcet, or paricalcitol.
Afsar B; Agca E; Turk S
J Clin Pharmacol; 2015 Nov; 55(11):1280-5. PubMed ID: 26032009
[TBL] [Abstract][Full Text] [Related]
5. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil-to-Lymphocyte Ratio and Erythropoietin Resistance among Maintenance Hemodialysis Patients.
Zhang J; Lu X; Wang S; Li H
Blood Purif; 2022; 51(8):708-713. PubMed ID: 34649238
[TBL] [Abstract][Full Text] [Related]
7. Preservation of anemia control and weekly ESA dosage after conversion from PEG-Epoetin beta to darbepoetin alfa in adult hemodialysis patients: the TRANSFORM study.
Donck J; Gonzalez-Tabares L; Chanliau J; Martin H; Stamatelou K; Manamley N; Farouk M; Addison J
Adv Ther; 2014 Nov; 31(11):1155-68. PubMed ID: 25367412
[TBL] [Abstract][Full Text] [Related]
8. Higher doses of erythropoietin-stimulating agents and hyporesponsiveness to their effects are associated with increased mortality among prevalent hemodialysis patients.
Nishio A; Chhatkuli BP; Ma JZ; Kalantari K
Blood Purif; 2013; 36(1):29-36. PubMed ID: 23735569
[TBL] [Abstract][Full Text] [Related]
9. Platelet-to-lymphocyte ratio better predicts inflammation than neutrophil-to-lymphocyte ratio in end-stage renal disease patients.
Turkmen K; Erdur FM; Ozcicek F; Ozcicek A; Akbas EM; Ozbicer A; Demirtas L; Turk S; Tonbul HZ
Hemodial Int; 2013 Jul; 17(3):391-6. PubMed ID: 23522328
[TBL] [Abstract][Full Text] [Related]
10. A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the Handling Erythropoietin Resistance With Oxpentifylline (HERO) trial.
Johnson DW; Pascoe EM; Badve SV; Dalziel K; Cass A; Clarke P; Ferrari P; McDonald SP; Morrish AT; Pedagogos E; Perkovic V; Reidlinger D; Scaria A; Walker R; Vergara LA; Hawley CM;
Am J Kidney Dis; 2015 Jan; 65(1):49-57. PubMed ID: 25115616
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of the erythropoiesis stimulating agent resistance index in incident hemodiafiltration and high-flux hemodialysis patients.
Marcelli D; Bayh I; Merello JI; Ponce P; Heaton A; Kircelli F; Chazot C; Di Benedetto A; Marelli C; Ladanyi E; Kroczak M; Stuard S; Grassmann A; Scatizzi L; Brand K; Canaud B
Kidney Int; 2016 Jul; 90(1):192-202. PubMed ID: 27178833
[TBL] [Abstract][Full Text] [Related]
12. IL-6 is an independent risk factor for resistance to erythropoiesis-stimulating agents in hemodialysis patients without iron deficiency.
Won HS; Kim HG; Yun YS; Jeon EK; Ko YH; Kim YS; Kim YO; Yoon SA
Hemodial Int; 2012 Jan; 16(1):31-7. PubMed ID: 22284696
[TBL] [Abstract][Full Text] [Related]
13. Platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios as markers of erythropoietin resistance in chronic haemodialysis patients: a multicentre cross-sectional study.
Valga F; Monzón T; Henriquez F; Santana-Del-Pino A; Antón-Pérez G
Nefrologia (Engl Ed); 2020; 40(3):320-327. PubMed ID: 31839207
[TBL] [Abstract][Full Text] [Related]
14. Estimate of maintenance EPO to darbepoetin alfa dose conversion ratio in a hospital-based dialysis patient population.
Sharma A; Yee J; Gandra SR; Khan I; Petersen J
Curr Med Res Opin; 2010 Nov; 26(11):2679-87. PubMed ID: 20942616
[TBL] [Abstract][Full Text] [Related]
15. Platelet-to-lymphocyte ratio predicts mortality better than neutrophil-to-lymphocyte ratio in hemodialysis patients.
Yaprak M; Turan MN; Dayanan R; Akın S; Değirmen E; Yıldırım M; Turgut F
Int Urol Nephrol; 2016 Aug; 48(8):1343-1348. PubMed ID: 27118565
[TBL] [Abstract][Full Text] [Related]
16. Relationship between insulin resistance and erythropoietin responsiveness in hemodialysis patients.
Abe M; Okada K; Soma M; Matsumoto K
Clin Nephrol; 2011 Jan; 75(1):49-58. PubMed ID: 21176750
[TBL] [Abstract][Full Text] [Related]
17. High Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Are Associated with Poor Survival in Patients with Hemodialysis.
Zhang J; Lu X; Wang S; Li H
Biomed Res Int; 2021; 2021():9958081. PubMed ID: 34104653
[TBL] [Abstract][Full Text] [Related]
18. Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study.
Winkelmayer WC; Chang TI; Mitani AA; Wilhelm-Leen ER; Ding V; Chertow GM; Brookhart MA; Goldstein BA
Am J Kidney Dis; 2015 Jul; 66(1):106-13. PubMed ID: 25943715
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil-to-lymphocyte ratio and platelet-tolymphocyte ratio in evaluation of inflammation in end-stage renal disease.
Ahbap E; Sakaci T; Kara E; Sahutoglu T; Koc Y; Basturk T; Sevinc M; Akgol C; Kayalar AO; Ucar ZA; Bayraktar F; Unsal A
Clin Nephrol; 2016 Apr; 85(4):199-208. PubMed ID: 26521887
[TBL] [Abstract][Full Text] [Related]
20. Inflammation, high ferritin, and erythropoietin resistance in indigenous maintenance hemodialysis patients from the Top End of Northern Australia.
Majoni SW; Ellis JA; Hall H; Abeyaratne A; Lawton PD
Hemodial Int; 2014 Oct; 18(4):740-50. PubMed ID: 24766376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
